Literature DB >> 15897995

Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model.

Cirle S Alcantara1, Xiao-Hong Jin, Gerly Anne C Brito, Benedito A Carneiro-Filho, Leah J Barrett, Robert M Carey, Richard L Guerrant.   

Abstract

Angiotensin II (ANG II) has been described in the regulation of intestinal secretion and absorption via angiotensin subtype 1 (AT(1)) and AT(2) receptors, respectively, in rats. We investigated the role that ANG II plays in the rabbit ileal-loop model of Clostridium difficile infection. Expression of AT(1), the more abundant ANG II receptor, was demonstrated in ileal loops, and an AT(1) receptor blocker, losartan, inhibited hypersecretion induced by C. difficile toxin A (mean volume : length ratio, 0.27+/-0.06 vs. 0.60+/-0.06 mL/cm in controls). Losartan also decreased production of ANG II in the ileum (0.48+/-0.06 vs. 0.87+/-0.12 pg/mg in controls), raising the possibility that ANG II may participate in a positive feedback loop involving the hypersecretory response. Our findings suggest that ANG II plays a significant role in the pathogenesis of C. difficile toxin-induced diarrhea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897995     DOI: 10.1086/430316

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.

Authors:  Cirle A Warren; Yuesheng Li; Gina M Calabrese; Rosemayre S Freire; Snjezana Zaja-Milatovic; Edward van Opstal; Robert A Figler; Joel Linden; Richard L Guerrant
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

2.  Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice.

Authors:  A R F Barreto; I C Cavalcante; M V Castro; A F T A Junqueira; M R Vale; R A Ribeiro; M H L P Souza; G A C Brito
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

3.  In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

Authors:  Kevin M D'Auria; Glynis L Kolling; Gina M Donato; Cirle A Warren; Mary C Gray; Erik L Hewlett; Jason A Papin
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

Review 4.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

5.  Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea.

Authors:  Alexander Y Kots; Byung-Kwon Choi; Maria E Estrella-Jimenez; Cirle A Warren; Scott R Gilbertson; Richard L Guerrant; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

Review 6.  The enterotoxicity of Clostridium difficile toxins.

Authors:  Xingmin Sun; Tor Savidge; Hanping Feng
Journal:  Toxins (Basel)       Date:  2010-07-14       Impact factor: 4.546

7.  Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.

Authors:  Cirle Alcantara Warren; Gina M Calabrese; Yuesheng Li; Sean W Pawlowski; Robert A Figler; Jayson Rieger; Peter B Ernst; Joel Linden; Richard L Guerrant
Journal:  BMC Infect Dis       Date:  2012-01-20       Impact factor: 3.090

8.  Synthesis and Pharmacological Screening of Pyridopyrimidines as Effective Anti-Diarrheal Agents through the Suppression of Cyclic Nucleotide Accumulation.

Authors:  Tiago Zaminelli; Elisa Magli; Francesco Frecentese; Caroline H Lescano; Rafael Campos; Irene Saccone; Angela Corvino; Paola Di Vaio; Flavia Giordano; Paolo Luciano; Ferdinando Fiorino; Elisa Perissutti; Vincenzo Santagada; Beatrice Severino; Giuseppe Caliendo; Gilberto De Nucci
Journal:  ChemistryOpen       Date:  2019-04-08       Impact factor: 2.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.